Announcements Trials

Browse Landscape

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Advanced Cancers 1

Interventions

Paclitaxel 292 Gemcitabine 254 Carboplatin 254 Cisplatin 251 Radiotherapy 219 Cyclophosphamide 218 Irinotecan 184 pembrolizumab 181 Docetaxel 174 Bevacizumab 166 Capecitabine 148 Nivolumab 141 Fluorouracil 132 Dexamethasone 125 Bortezomib 123 Oxaliplatin 115 Cytarabine 113 Erlotinib Hydrochloride 112 Temozolomide 110 Sorafenib 110 Doxorubicin 106 Rituximab 105 Leucovorin 105 Etoposide 105 Filgrastim 99 Everolimus 97 Lenalidomide 95 Pemetrexed 90 Ipilimumab 90 fludarabine phosphate 84

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Completed × LY 2275796 × Clear all

NCT00903708 2012-07-30

LY2275796 in Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Completed

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡